EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Luigi Padeletti, Davíð O. Arnar, Lorenzo Boncinelli, +13

EP Europace

Heart FailureCardiac AnaesthesiaDevice TherapyHealth LawDigital Health +19

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop, +135

The Lancet

Hematological MalignancyCell TherapyTransplantationMedicineHematology +7

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus, +92

The Lancet Haematology

Hematological MalignancyLymphoid NeoplasiaCell TherapyMedicineImmunology +8

Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia

Bruno Fattizzo, Robin Ireland, Alan Dunlop, +12

Leukemia

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, +56

Blood Advances

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

Nicolás Martínez‐Calle, Edward Poynton, Alia Alchawaf, +21

British Journal of Haematology

Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines

Shireen Kassam, Heidi Goenaga‐Infante, Lenushka Maharaj, +3

Cancer Chemotherapy and Pharmacology

Hematological MalignancyTumor BiologyLymphoid NeoplasiaMalignant Blood DisorderImmunology +4

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Ferras Alwan, Annie He, Silvia Montoto, +10

AIDS

Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies

Jane Stevens, Rachel Waters, Christina Sieniawska, +6

British Journal of Haematology

Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-in-Human Trial (CALM) in Adult Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Charlotte Graham, Deborah Yallop, Agnieszka Jóźwik, +20

Blood